Advertisement

Positron Emission Tomography of Brain Glucose Metabolism with [18F]Fluorodeoxyglucose in Humans

  • Albert GjeddeEmail author
Protocol
Part of the Neuromethods book series (NM, volume 90)

Abstract

The practice of neuroimaging, first by SPECT and PET, and then by magnetic resonance imaging (MRI), greatly contributes to the fundamental understanding of neuroanatomical correlates of brain function. It reveals novel treatment options in disciplines such as neurology, neurosurgery, and neuropsychiatry. The new opportunities afforded by neuroimaging yield images not only of brain tissue structure of an ever-increasing power of resolution but also, and perhaps more importantly, of the basic organization of brain work. Understanding brain work requires insight into the roles of regional cerebral blood flow and energy metabolism, obtained by measures of oxygen and glucose consumption rates, neuronal network and neurotransmitter system activity, and most recently the abnormal deposition of amyloid-beta in brain tissue and the resulting abnormalities of second messenger cascades that promise to reveal the origins of neurodegeneration.

The quantification of the brain images, acquired by means of the different methods of neuroimaging, is vital to the improved understanding and interpretation of experimental and clinical findings that are reported at a significant and ever-increasing rate. While many brain-imaging agents, such as markers of amyloid-beta in dementia, are studied with the ultimate goal of application to clinical prognostication and differential diagnosis, other agents are fundamental research tools for understanding new drugs, such as antipsychotics, antidepressants, and anxiolytics, as well as drugs for the relief of devastating neurological disorders such as multiple sclerosis, stroke, and dementia. Some of the earliest markers were tracers of blood flow used with autoradiography, SPECT, and PET, but in 1977, Sokoloff et al. published the seminal description of the use of labeled 2-deoxyglucose to trace the rate of glucose phosphorylation in brain, initially by autoradiography but soon after also by positron emission tomography of the brain uptake of the glucose analog 2-fluoro-2-deoxyglucose, labeled with the positron emitter fluorine-18 (FDG). The basis for the use of this tracer ex as well as in vivo is a deceptively simple model of brain glucose metabolism that includes only the steps of the bidirectional transport of glucose and glucose analogs across the blood-brain barrier imposed by the tight junctions between the endothelial cells of the brain’s capillaries, and the step of phosphorylation enabled by the presence of the enzyme hexokinase in the cells of the brain.

This chapter provides a brief explanation of the quantitative method of PET imaging with FDG used by neuroscientists for the last 40 years to quantify the uptake and metabolism of this tracer in terms of the absolute rate of glucose phosphorylation in brain tissue during the period following the tracer administration. The chapter also highlights the issues of relative precision and accuracy of the method applied to high-resolution research tomography. It includes a description of the basic elements of quantification, and, in particular, of the necessary mathematical modeling of the dynamic brain records of the uptake of the tracer, both to justify the role of such modeling in study design and to validate some of the simplifications that are necessary in some clinical settings. As fundamental tools of neuroimaging, quantification and kinetic modeling are as important as image reconstruction and structural identification of regions of interest. The quantitative methods presented here continue to underpin the routine approaches to measures of brain glucose consumption rates in different regions of the brain and hence matter to most clinicians and clinician scientists involved in the neuroimaging practice of regional glucose phosphorylation rates.

Key words

Positron emission tomography (PET) Fluorodeoxyglucose (FDG) Cerebral metabolic rate of glucose (CMRglc) Neurokinetics Kinetic modeling In vivo autoradiography Brain imaging 

Abbreviations

CBF

Cerebral blood flow

CMRglc

Cerebral metabolic rate of glucose

CMRO2

Cerebral metabolic rate of oxygen

FDG

[18F]fluorodeoxyglucose

GLUT

Glucose transporter

HRRT

High-resolution research tomograph

LC

Lumped constant

MRI

(Nuclear) magnetic resonance imaging

PET

Positron emission tomography

ROI

Region(s) of interest

SPECT

Single-photon emission computed tomography

VOI

Volume(s) of interest

Notes

Acknowledgements

Danish National Science Foundation Center of Excellence grants 2001 and 2006, Global Excellence Award 2010, Capital Region, Denmark.

References

  1. 1.
    Berti V et al (2013) Back to the future: the absolute quantification of cerebral metabolic rate of glucose. Clin Transl Imaging. doi: 10.1007/s40336-013-0030-2 Google Scholar
  2. 2.
    Gjedde A, Bauer B, Wong DF (2011) Neurokinetics: the dynamics of neurobiology in vivo. Springer, New YorkCrossRefGoogle Scholar
  3. 3.
    Gjedde A (2008) Functional brain imaging celebrates 30th anniversary. Acta Neurol Scand 117(4):219–223PubMedCrossRefGoogle Scholar
  4. 4.
    Gjedde A (1980) Rapid steady-state analysis of blood-brain glucose transfer in rat. Acta Physiol Scand 108(4):331–339PubMedCrossRefGoogle Scholar
  5. 5.
    Sokoloff L et al (1977) The [14C]deoxyglucose method for the measurement of local cerebral glucose utilization: theory, procedure, and normal values in the conscious and anesthetized albino rat. J Neurochem 28(5):897–916PubMedCrossRefGoogle Scholar
  6. 6.
    Reivich M et al (1979) The [18F]fluorodeoxyglucose method for the measurement of local cerebral glucose utilization in man. Circ Res 44(1):127–137PubMedCrossRefGoogle Scholar
  7. 7.
    Gjedde A (1982) Calculation of cerebral glucose phosphorylation from brain uptake of glucose analogs in vivo: a re-examination. Brain Res 257(2):237–274PubMedCrossRefGoogle Scholar
  8. 8.
    Gjedde A et al (1985) Comparative regional analysis of 2-fluorodeoxyglucose and methylglucose uptake in brain of four stroke patients. With special reference to the regional estimation of the lumped constant. J Cereb Blood Flow Metab 5(2):163–178PubMedCrossRefGoogle Scholar
  9. 9.
    Hasselbalch SG et al (2001) The [18F]fluorodeoxyglucose lumped constant determined in human brain from extraction fractions of [18F]F-fluorodeoxyglucose and glucose. J Cereb Blood Flow Metab 21(8):995–1002PubMedCrossRefGoogle Scholar
  10. 10.
    Bass L et al (2011) Analogue tracers and lumped constant in capillary beds. J Theor Biol 285(1):177–781PubMedCrossRefPubMedCentralGoogle Scholar
  11. 11.
    Kuwabara H, Evans AC, Gjedde A (1990) Michaelis-Menten constraints improved cerebral glucose metabolism and regional lumped constant measurements with [18F]fluorodeoxyglucose. J Cereb Blood Flow Metab 10(2):180–189PubMedCrossRefGoogle Scholar
  12. 12.
    Kuwabara H, Gjedde A (1991) Measurements of glucose phosphorylation with FDG and PET are not reduced by dephosphorylation of FDG-6-phosphate. J Nucl Med 32: 692–698PubMedGoogle Scholar
  13. 13.
    Kuikka JT et al (1991) Mathematical modelling in nuclear medicine. Eur J Nucl Med 18:351–362PubMedCrossRefPubMedCentralGoogle Scholar
  14. 14.
    Sheppard CW (1948) The theory of the study of transfers within a multi-compartment system. J Appl Phys 19(70)Google Scholar
  15. 15.
    Rescigno A, Beck J (1972) Compartments. In: Rosen R (ed) Foundations of mathematical biology, 1st edn. Academic, New York, pp 255–322CrossRefGoogle Scholar
  16. 16.
    Rescigno A, Beck J (1987) The use and abuse of models. J Pharmacokinet Biopharm 15: 327–344PubMedCrossRefGoogle Scholar
  17. 17.
    Ghosh A, Cheung YY, Mansfield BC, Chou JY (2005) Brain contains a functional glucose-6-phosphatase complex capable of endogenous glucose production. J Biol Chem 280: 11114–11119PubMedCrossRefGoogle Scholar
  18. 18.
    Gejl M, Lerche S, Egefjord L, Brock B, Møller N, Vang K, Rodell AB, Bibby BM, Holst JJ, Rungby J, Gjedde A (2013) Glucagon-like peptide-1 (GLP-1) raises blood-brain glucose transfer capacity and hexokinase activity in human brain. Front Neuroenergetics 5:2. doi: 10.3389/fnene.2013.00002. eCollection 2013 PubMedCrossRefPubMedCentralGoogle Scholar
  19. 19.
    Gjedde A (1981) High- and low-affinity transport of D-glucose from blood to brain. J Neurochem 36(4):1463–1471PubMedCrossRefGoogle Scholar

Copyright information

© Springer Science+Business Media New York 2014

Authors and Affiliations

  1. 1.Department of Neuroscience and Pharmacology, Faculty of Health and Medical SciencesUniversity of CopenhagenCopenhagenDenmark

Personalised recommendations